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Abstract
Cross-regulation of Toll-like receptor responses by cytokines is essential for effective host defense, 
avoidance of toxicity, and homeostasis, but the underlying mechanisms are not well understood. A 
comprehensive epigenomic approach in human macrophages showed that the proinflammatory 
cytokines TNF and type I IFNs induce transcriptional cascades that alter chromatin states to 
broadly reprogram TLR4-induced responses. TNF tolerized inflammatory genes to prevent 
toxicity, while preserving antiviral and metabolic gene induction. Type I IFNs potentiated TNF 
inflammatory function by priming chromatin to prevent silencing of inflammatory NF-κB target 
genes. Priming of chromatin enabled robust transcriptional responses to weak upstream signals. 
Similar chromatin regulation occurred in human diseases. Our findings reveal that signaling 
crosstalk between IFNs and TNF is integrated at the level of chromatin to reprogram inflammatory 
responses, and identify new functions and mechanisms of action of these cytokines.
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Introduction
Tumor necrosis factor (TNF) is important in innate immunity, inflammation, and host 
defense against microbial pathogens1. TNF is also a key pathogenic cytokine and driver of 
chronic inflammation in multiple autoimmune and inflammatory diseases2. Classical 
inflammatory activation of cells by TNF is mediated by canonical NF-κB and MAPK 
signaling that activates well known inflammatory genes such as IL1 and IL6. TNF also has 
potent paradoxical anti-inflammatory functions (discussed in ref3) that limit inflammation-
associated toxicity4. Perhaps the most potent suppressive mechanism induced by TNF is 
‘cross-tolerance’3, which resembles classical endotoxin tolerance5 in that various TLR 
ligands and inflammatory stimuli are unable to induce transcription of select inflammatory 
genes. Much less is known about cross-tolerance induction by TNF than endotoxin 
tolerance, and about how the tolerizing functions of TNF are over-ridden such that TNF is 
able to drive chronic inflammation.
Type I interferons (IFNs) activate the Jak-STAT signaling pathway to induce expression of 
interferon-stimulated genes (ISGs) that are activated by STAT proteins via binding to 
conserved ISRE and GAS DNA elements6. ISGs include antiviral proteins, chemokines, and 
antigen-presenting molecules, and thus type I IFNs can promote antiviral and immune 
responses, and have been implicated in autoimmune diseases. However, type I IFNs can also 
play a suppressive role in certain chronic infections and in multiple sclerosis6. Distinct IFN 
functions may be related to context dependent effects on inflammatory NF-κB-driven genes, 
as IFNs can either suppress cytokines or contribute to increased cytokine production in 
diseases such as SLE, increased inflammation when bacterial infections follow viral 
infections, and to microbiota-mediated priming of cytokine responses6–9. Mechanisms by 
which type I IFNs regulate inflammatory NF-κB target genes, which are not targets of the 
Jak-STAT signaling pathway, are not known10,11.
Potent inflammatory activators of macrophages such as TLR ligands activate signaling via 
NF-κB, MAPK-AP-1 and IRF3 pathways to induce expression of inflammatory cytokine 
genes12. The ability of signal-responsive transcription factors (TFs) to induce transcription is 
modulated by chromatin states at gene regulatory elements (promoters and enhancers)13–17. 
Activation of many TLR-inducible genes, including Il6, Il12b and Ifnb, requires increasing 
chromatin accessibility by deposition of positive histone marks and remodeling of 
nucleosomes to create nucleosome-free regions at promoters and enhancers13–15. More 
recent work has shown that environmental cues can fine tune the macrophage enhancer 
repertoire18–23. Induction of new enhancers can explain tissue-specific macrophage gene 
expression, and raises the possibility that enhancer remodeling can alter cellular responses to 
environmental signals. However, analysis of the effects of epigenomic remodeling on 
cellular responses to secondary inflammatory challenges has been limited. Furthermore, 
little is known about whether signaling crosstalk occurs in the nucleus at the level of 
chromatin during an inflammatory TLR-driven response.
It was previously reported that TNF induces a state of ‘cross-tolerance’ in which various 
TLR ligands are unable to induce transcription of the canonical inflammatory NF-κB-
dependent cytokines IL-1β, IL-6 and TNF, and which protects mice from endotoxin lethality 
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in vivo3. In the current study, we wished to understand TNF-induced cross-tolerance in 
greater depth, and to test whether macrophages could escape from cross-tolerance; 
abrogation of this feedback mechanism could provide an explanation for how TNF can drive 
sustained unremitting inflammation in a chronic setting. We took a comprehensive and 
integrated genome-wide approach using RNA-seq, ChIP-seq, and ATAC-seq24 with digital 
footprinting25 to investigate the regulation of TLR4 responses by TNF. We discovered that 
type I IFNs effectively abrogate TNF-induced cross-tolerance by priming chromatin to 
enable robust transcriptional responses to weak signals. These findings reveal mechanisms 
by which cytokine signaling crosstalk is integrated at the epigenomic level, and identify a 
new function and mechanism of action for type I IFNs.
Results
TNF Reprograms the LPS response in human macrophages
Previous work showed that TNF pretreatment strongly attenuates LPS-induced signaling and 
chromatin remodeling upon secondary challenge3,5. To gain insight into gene regulation in 
TNF-induced tolerance, we performed transcriptomic analysis using RNA sequencing 
(RNA-seq). We used our previously established system in which primary human 
macrophages are treated with TNF for 24 hours prior to LPS challenge3 (Fig. 1a) and 
focused our analysis on the 1,574 genes that were strongly induced (>3-fold) in response to 
LPS. Clustering of LPS-inducible genes by patterns of gene expression revealed 12 clusters 
that could be assembled into 6 major classes (Fig. 1b, Supplementary Fig. 1a and Methods). 
Two classes of robustly LPS-inducible genes were minimally (Class 1, n = 466) or weakly 
(Class 2, n = 245) induced by LPS in macrophages pretreated with TNF (Fig. 1b). Following 
previous nomenclature, we termed these ‘tolerized’ or ‘T’ genes5,26. Class 1 was enriched 
for gene ontology (GO) terms related to ‘defense response’ and ‘inflammatory response’ 
(Fig. 1c), and included many pro-inflammatory cytokines (Fig. 1d) and NF-κB target genes 
(Fig. 1e). Thus, TNF-induced cross-tolerance is broadly similar to endotoxin tolerance26,27 
in transcriptional silencing of inflammatory NF-κB target genes.
LPS effectively and paradoxically induced expression of various genes in TNF-treated cells 
(Fig. 1b, Classes 3–6, and Supplementary Fig. 1a and 1b), despite minimal LPS-induced 
signaling3 (see also below). In line with previous reports of endotoxin tolerance, we termed 
these ‘nontolerized’ or ‘NT’ genes26,28. Class 3 (n = 403) is comprised of genes strongly 
induced by LPS in both naïve and TNF-treated cells; Class 3 NT genes are most clearly 
regulated in a directly opposite manner from T genes. In contrast, genes in Classes 4 (n = 
285) and 5 (n = 82) were substantially expressed in TNF-treated cells and superinduced by 
secondary LPS challenge (Fig. 1b and Supplementary Fig. 1a), thus revealing cooperation 
and even synergy (Class 4A, Supplementary Fig. 1a) between the ‘tolerizing’ factor TNF 
and LPS.
In addition to different expression patterns, the NT gene classes had distinct functions as 
revealed by GO analysis. Class 3 genes were enriched for cytokine and IFN signaling via 
Jak-STAT pathway, Class 4 genes were enriched for metabolic processes, and Class 5 and 6 
contain additional genes important in lipid metabolic processes (Fig. 1c and 1d; complete 
list of genes in all six classes is provided in Supplementary Table 1).
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The gene classes also differed in transcription factor binding motifs that were enriched in 
their promoters (Fig. 1e). Class 1 T gene promoters were most significantly enriched in NF-
κB and NFE2L1 motifs, Class 3 NT in ISREs (bind type I IFN-activated ISGF3), and Class 
4 NT genes in binding sites for SREBP, which drives expression of cholesterol pathway and 
lipid metabolism genes. Thus, in addition to different patterns of expression and different 
functions, the gene classes have distinct mechanisms of regulation. As predicted, various 
Class 3 NT genes were dependent on type I IFN signaling, whereas Class 4 NT genes were 
not (Supplementary Fig. 1c).
The gene classes could also be distinguished based on kinetics of induction by TNF 
(Supplementary Fig. 2a). Class 1 (T genes) is largely composed of early TNF-induced genes, 
which peak at 1–3 hr and decrease in expression by 24 hr. In contrast, Class 3 and Class 4 
genes exhibited delayed induction kinetics; unlike the gradual increase of expression of 
Class 3 genes, Class 4 exhibited induction only at the late (24 hr) time point. We then 
compared the behavior TNF-induced (n=433, 1 or 3 hr) and LPS-induced (n=1,219, 3 hr) 
genes to test the possibility that TNF tolerance only affects TNF-induced genes. Strikingly, 
TNF tolerized a large fraction of LPS-inducible genes that were not induced by TNF 
(Supplementary Fig. 2b), supporting the idea of crosstolerance.
Collectively, the results reveal that TNF extensively reprograms the LPS response, with 
TNF-induced ‘cross-tolerance’ representing one component of ‘reprogramming’. The TNF-
reprogrammed state appears to differ from classical endotoxin tolerance by the expression of 
IFN/cytokine-driven genes (Class 3) and lipid metabolic genes (Class 4–6) upon LPS 
challenge.
TNF regulates chromatin and TFs to reprogram LPS response
TLR4 signaling is almost completely abrogated in macrophages pretreated with TNF or 
endotoxin, and epigenetic mechanisms have been implicated in tolerance. Consistent with an 
epigenetic mechanism, TNF-induced tolerance was sustained for at least 48 h after the 
washout of TNF (Supplementary Fig. 2c). As epigenetic regulation has been studied for only 
a small number of T genes, and not for NT genes, we performed genome wide analysis of 9 
histone marks using ChIP-seq, and of chromatin accessibility using ATAC-seq to gain 
greater insight into the role of chromatin regulation in TNF-induced reprogramming of the 
TLR4 response.
We found that tolerization with TNF attenuated LPS-induced increases of the positive 
histone marks H4-Ac and H3K4me3 (associated with open chromatin and transcription), and 
of increased chromatin accessibility (ATAC-seq reads) (Fig. 2a, quantitation shown in 
Supplementary Fig. 3a; representative gene tracks are shown in Fig. 2b and Supplementary 
Fig. 3b). These results are in accord with a model that in ‘tolerized’ cells LPS is unable to 
generate a sufficiently strong signal to induce chromatin remodeling that is required for 
effective induction of transcription3,26,29,30. We also found that tolerization attenuated LPS-
induced increases in H2BK120 ubiquitination (H2Bub) (Fig. 2a), a positive mark that serves 
to increase H3K4me3 and open chromatin and is a prerequisite for H3K4me3 in other 
systems. This implies that inability of LPS to generate signals that lead to H2Bub 
contributes to the tolerization of these genes.
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Genes in nontolerized Classes 3–6 exhibited distinct chromatin regulation profiles. Notably, 
Class 3 NT genes, functionally related to IFN/cytokine Jak-STAT signaling, were ‘marked’ 
by H2Bub and H4-Ac after TNF treatment, which was associated with substantial 
inducibility of H3K4me3, opening of chromatin, and robust induction of gene expression in 
response to weak signaling upon LPS challenge (Fig. 2a and Supplementary Fig. 3a; 
representative gene tracks are shown in Fig. 2b and Supplementary Fig. 3b). This suggests 
that marking or ‘priming’ of Class 3 NT genes by H2Bub and H4-Ac enables chromatin 
remodeling and transcriptional responses even to weak signals.
Class 4–6 genes differed from Class 1–3 genes in that H2Bub, H3K4me3, and open 
chromatin (ATAC-seq read density) were lower at baseline in naive macrophages and weakly 
inducible by LPS (Fig. 2a and Supplementary Fig. 3a, c). Instead, these positive marks and 
opening of chromatin were induced during TNF stimulation (Fig. 2a, b and Supplementary 
Fig. 3a, b), suggesting that their epigenetic profile is ‘primed’ by TNF. Patterns of regulation 
were confirmed in additional replicates (Supplementary Fig. 4a), and for select genes by 
ChIP-qPCR and FAIRE in additional donors (Supplementary Fig. 4b and data not shown). 
Exceptions where histone marks did not correlate with transcriptomic changes are discussed 
in Supplementary Note 1; ChIP-seq data on other less informative or repressive histone 
marks are shown in Supplementary Fig. 3c–e. Regulation of histone marks and chromatin 
accessibility at enhancers in TNF-treated cells paralleled that of promoters but was 
quantitatively less dynamic (Supplementary Fig. 5a). In addition, CpG islands11, super-
enhancers31, and latent enhancers20 did not correlate with patterns of regulation of the 
different gene classes (Supplementary Fig. 5b–d). Overall, the data support a model whereby 
TNF alters chromatin states at TLR4-inducible gene promoters to reprogram the TLR4-
induced gene response to silence expression of inflammatory NF-κB-dependent genes, while 
augmenting the expression of cytokine-induced, antiviral, and metabolic genes.
To identify candidate transcription factors that could explain the differential expression and 
regulation of the distinct gene classes, we identified digital footprints (p < 10−10) 
‘underneath’ ATAC-seq promoter peaks followed by matching to all known transcription 
factor motifs. This approach has the advantage compared to motif enrichment in that it 
identifies sites that are actually bound by TFs, rather than just motifs that have the potential 
to bind TFs. Examples of well-delineated TF footprints are shown in Fig. 2c and 
Supplementary Fig. 4c. Footprinting analysis recovered binding of PU.1/Ets elements, of 
NF-Y and SP-1 core promoter elements32, and inducible NF-κB element binding, thus 
supporting the validity of the approach (Fig. 3a). Strikingly, footprinting analysis clearly 
identified distinguishing features among the promoters in the different gene classes (Fig. 3a). 
The most salient class-specific characteristics were inducible occupancy of IRF and ISRE 
sites at Class 3 NT gene promoters, which is consistent with regulation by IFNs and 
cytokines, and of AP-1 sites under T and TL conditions in Class 4 gene promoters. 
Accordingly, TNF induced sustained expression of AP-1 proteins (Fig. 3b) and induction of 
these genes was sensitive to MAPK inhibitors (ref.26 and data not shown). Patterns of 
expression of members of relevant transcription factor families are shown in Fig. 3c and 
Supplementary Table 1. Additional detailed description of footprinting results is provided in 
Supplementary Note 2.
Park et al. Page 5
Nat Immunol. Author manuscript; available in PMC 2018 February 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Footprinting analysis of enhancers showed inducible binding of NF-κB, IRF, AP-1 and C/
EBP-AP-1 sites (Supplementary Fig. 5e) similar to inducible binding that was detected at 
promoters, suggesting that enhancers are also responsive to TNF and LPS. However, the 
occupancy of TF binding sites at enhancers was more similar among the six gene classes 
than was occupancy of promoters. In accord with the footprinting analysis, de novo motif 
enrichment analysis under enhancer ATAC-seq peaks using HOMER showed similarity 
among the gene classes (Supplementary Fig. 5f). Overall, the ChIP-seq and footprinting 
results provide insight into the distinct regulatory logic of the different gene classes, and 
suggest a role for IRF/ISGF3 (Class 3 NT) or AP-1 (Class 4 NT) for opening chromatin and 
allowing these genes to escape tolerance.
Expression of inflammatory gene classes in human diseases
To address whether our findings reflect inflammatory gene regulation in vivo, we examined 
expression of the six classes of LPS-inducible genes in human disease states. First, we 
analyzed gene expression in monocytes from sepsis patients collected during sepsis (where 
they are exposed to both endotoxin and TNF) and after recovery, and stimulated ex vivo with 
LPS28. Strikingly, genes in Class 1 and 2 exhibited tolerization in vivo that was reversed 
when patients recovered (Fig. 3d), thus recapitulating our in vitro model. Genes in classes 4–
6 also exhibited similar expression patterns in sepsis patients as in our system, but Class 3 
genes exhibited limited inducibility by LPS ex vivo. This reinforces the notion that 
inducibility of IFN target genes is a feature that distinguishes TNF-induced reprogramming 
from endotoxin tolerance. We also found that expression of genes in two non-tolerized gene 
sets, Class 3 and Class 4, was significantly elevated in synovial macrophages from patients 
with RA, a condition where inflammation is driven by TNF (Fig. 3e and 3f). Overall, these 
results support that the patterns of gene regulation and classes of inflammatory genes we 
identified in our model system reflect aspects of inflammatory gene regulation in vivo in 
infectious/inflammatory disease states.
Type I IFNs abrogate TNF-mediated tolerance
Building on previous work that inhibition of glycogen synthase kinase 3 (GSK3) reverses 
TNF-induced tolerance and GSK3 regulates IFN production3,5,33, we found that reversal of 
tolerization of IL6 by GSK3 inhibition was mediated by increased type I IFNs 
(Supplementary Fig. 4d–f). We tested the effects of type I IFNs on TNF-induced tolerance 
genome-wide using RNA-seq. Addition of exogenous IFN-α together with TNF (Fig. 4a) 
significantly restored LPS-inducibility to the majority of Class 1 T genes (60.7%, 283/466) 
(Fig. 4b and 4c), indicating a broad but gene-specific reversal of tolerance. IFN-α 
differentially affected expression of the 6 TLR4-induced gene classes and few genes in the 
NT Classes 4–6 (21–23%) were upregulated by IFN-α (Fig. 4b). Notably, type I IFN did not 
reverse tolerization of TNF and IL6 by LPS in the classic endotoxin model (Supplementary 
Fig. 4g). IFN-α increased LPS-induced Class 1 gene expression only in TNF-treated cells 
(Fig. 4b), in accord with extensive literature that Class 1 T genes are not canonical ISGs. 
Thus, crosstalk between IFN and TNF couples IFN signaling with Class 1 NF-κB target 
genes and prevents their tolerization.
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We tested whether IFN-α could augment LPS-induced signaling in tolerized macrophages. 
As expected3, robust LPS-induced I-κBα degradation and activation of IKK and ERK were 
observed in naïve macrophages but strongly blunted in TNF-tolerized macrophages (Fig. 
4d). In contrast to its effects on gene expression, IFN-α did not reverse these defects in 
proximal LPS-induced TLR signaling (Fig. 4d, lanes 5–8 versus 9–12). IFN-α also did not 
affect TNF-induced expression of noncanonical NF-κB proteins suggested to play a role in 
tolerance27,34. These results indicate that IFN-α strongly affects transcriptional responses of 
Class 1 and 2 genes without substantially altering proximal TLR signaling defects.
The gene-specific effects of IFN-α (Fig. 4b, right panels), together with its ability to enable 
robust induction of T genes in response to very weak TLR4-induced proximal signals in 
TNF-pretreated cells, suggested that IFN-α exerts its effects in the nucleus at the level of 
gene regulation. To test this idea, we first confirmed that IFN-α-mediated abrogation of gene 
tolerization occurs at the level of transcription by measuring primary transcripts (Fig. 4e). 
Furthermore, ChIP-qPCR experiments showed that IFN-α overcame the TNF-induced block 
in RNA polymerase II (pol II) recruitment to the tolerized gene IL6 (Fig. 4f). These results 
support the notion that IFN-α signaling acts in the nucleus to regulate gene expression.
Crosstalk between IFN and TNF primes chromatin at T genes
We reasoned that IFN-α could amplify transcriptional responses of Class 1/2 genes to weak 
LPS signals in TNF-treated macrophages by remodeling chromatin. This notion was 
supported by FAIRE assays showing that IFN-α promoted opening of chromatin at the IL6 
promoter in TNF-treated macrophages (Fig. 5a). We then used ATAC-seq and ChIP-seq to 
analyze chromatin accessibility and the positive H2Bub and H3K4me3 marks genome-wide. 
IFN-α did not significantly increase ATAC-seq read counts at the majority of Class 1 genes 
in resting or LPS-stimulated naïve cells (Supplementary Fig. 6b). However, the combination 
of IFN-α and TNF resulted in increased chromatin accessibility at Class 1 gene promoters, 
with a further increase upon LPS stimulation (Fig. 5b and Supplementary Fig. 6b). A similar 
signal-responsive but quantitatively less dynamic pattern was observed at Class 1 gene 
enhancers (Supplementary Fig. 6c). Representative gene tracks are shown in Fig. 5c and 
Supplementary Fig. 6d.
A similar pattern of increased H3K4me3, which marks open chromatin, was observed when 
IFN-α was added in the T and TL conditions (Fig. 5b, c and Supplementary Fig. 6b, d). The 
breadth of H3K4me3 peaks and extension of this ‘promoter mark’ into gene bodies, which is 
associated with increased transcription35, was increased by IFN-α in a similar manner (Fig. 
5d). Interestingly, IFN-α and TNF cooperated to increase H3K4me3 peak breadth. Finally, 
H2Bub, a prerequisite for H3K4me3 in other systems, was also increased when IFN-α and 
TNF were added together. These results are strikingly different from results obtained in the 
absence of IFN-α, where chromatin remained closed (Fig. 2a and Supplementary Fig. 6b). 
The results show that addition of IFN-α together with TNF conditions or ‘primes’ chromatin 
at Class 1 gene promoters, which can facilitate transcriptional responses to weak LPS 
signals. In accord with H3K4me3 marking open chromatin, in IFN-α- plus TNF-treated 
macrophages stimulated with LPS (IFN/T-L condition) we observed broad ATAC-seq peaks 
that extended into gene bodies (Fig. 5c, e). Thus, opening of chromatin at Class 1 genes is a 
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salient feature of IFN-α action in TNF-treated macrophages, and IFN-α and TNF cooperate 
to prevent gene silencing.
IFN and TNF cooperate to recruit TFs to Class 1 promoters
We addressed the possibility that opening of chromatin at Class 1 gene promoters under 
tolerizing conditions requires cooperation between TFs induced by IFN-α and TNF. De 
novo motif analysis of TF footprints under ATAC-seq peaks in IFN/T-L conditions revealed 
that under IFN-stimulated conditions these promoters newly gain occupancy of IRF sites 
(Fig. 6a). A similar ISRE site was enriched in Class I gene enhancers (Supplementary Fig. 
7a). Motif analysis of TF footprints in the most ‘primed’ chromatin, as defined by peaks 
with high read density of ATAC-seq, H2Bub or H3K4me3, revealed enrichment of NF-κB 
and IRF motifs (Fig. 6b). Most strikingly, peaks with the highest chromatin accessibility 
were associated with a composite NF-κB/IRF motif (Fig. 6b, red font), and several IRFs 
were induced in IFN-α-treated tolerized macrophages (Fig. 6c and Supplementary Fig. 7b). 
This suggested that coordinate binding by TNF-induced NF-κB and IFN-induced IRFs to 
Class I promoters contributes to increased chromatin accessibility.
This notion was supported by ChIP-seq data that upon TNF + IFNα treatment a large 
fraction of IRF1 binding peaks at Class 1 gene promoter elements (ATAC-seq peaks) 
colocalized with NF-κB p65 peaks (Fig. 7a, p = 0.0059 relative to random genes). 
Representative gene tracks showing alignment of p65 and IRF1 binding peaks are depicted 
in Fig. 7b and Supplementary Fig. 7c). Increased co-recruitment of IRF1 and p65 after TNF 
+ IFNα treatment was confirmed for a subset of genes by ChIPq-PCR (Fig. 7c and 
Supplementary Fig. 7d). Significantly increased colocalization of IRF1 and p65 binding was 
also observed when an independent data set (GSE43036) was used to define IRF1 peaks 
(Supplementary Fig. 7e, f). Overall, these results support a model (Supplementary Fig. 8) 
whereby TNF-induced NF-κB and IFN-α-induced IRFs bind coordinately to promoters of 
Class 1 tolerized genes and cooperate to maintain an open and ‘primed’ chromatin state, 
which enables strong transcriptional responses to weak LPS-induced signals.
Escape of IL6 transcription from suppression by IL-10
One potential consequence of ‘priming’ of chromatin in IFN-α + TNF-treated macrophages 
is a change in transcriptional requirements for LPS-induced gene activation. We tested this 
idea for IL6, a Class 1 gene whose induction by LPS in naïve macrophages is dependent on 
de novo protein synthesis (which is required for increased chromatin accessibility)11,30, and 
is suppressed by the potent anti-inflammatory cytokine IL-10. In contrast to naïve LPS-
stimulated macrophages (Fig. 7d, bars 3, 4), in IFN-α + TNF-treated macrophages IL6 
expression was strongly induced by LPS in the presence of the protein synthesis inhibitor 
cycloheximide (Fig. 7d, bars 7, 8). IL-10 essentially completely suppressed LPS-induced 
IL6 expression in naïve macrophages, but only partially in IFN-α-primed tolerized 
macrophages (Fig. 7e). These results indicate that ‘priming’ by crosstalk between IFN-α and 
TNF changes the regulatory logic of gene expression and can make genes resistant to 
suppression by anti-inflammatory stimuli, thereby promoting sustained TNF-driven 
inflammation.
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Chromatin accessibility in SLE monocytes
Type I IFNs have been proposed to contribute to SLE pathogenesis by opposing tolerance 
induction36. We reasoned that SLE monocytes, which have been exposed to IFNs, TNF and 
TLR ligands in vivo, might exhibit an altered epigenomic/chromatin landscape that reflects 
some of the IFN-mediated regulatory mechanisms we have described in this study. Pearson 
correlation analysis showed that the chromatin accessibility profile of SLE monocytes 
stimulated with LPS ex vivo (labelled SLE-L) was closely correlated with the profile of IFN-
α-treated tolerized cells stimulated with LPS in our system (labelled IFN/T-L) (Fig. 8a, 
shown in red font), but did not correlate with LPS-stimulated naïve (Fig. 8a, rows 2,4,5) or 
tolerized (rows 13–16) cells. Examination of gene tracks of individual genes (Fig. 8b) 
revealed that in SLE monocytes LPS induced a broad region of chromatin accessibility that 
extended into the gene bodies, reminiscent of results obtained with IFN-α-treated tolerized 
cells (IFN/T-L condition, Fig. 8b and 5c, e). This is in accord with the broad H3K4me3 
peaks in our system (Fig. 5d, e) and reported in SLE monocytes37.
Given the importance of type I IFNs in SLE, we next turned our attention to the IFNB1 
gene. Strikingly, IFN-α led to a massive superinduction of IFNB1 by LPS, but only in cells 
that were also treated with TNF (Fig. 8c, bar 8). Thus, IFNB1 resembles Class 1 genes in 
that induction requires preconditioning by IFN-α and TNF followed by LPS challenge. LPS 
challenge of IFN-α + TNF-treated cells induced a broad region of chromatin accessibility at 
IFNB1 that extended from the promoter into the gene body, and similar results were 
obtained using LPS-stimulated SLE, but not control, monocytes (Fig. 8d). To further 
compare SLE monocytes with IFN-α-primed tolerized monocytes, we performed de novo 
motif analysis underneath ATAC seq peaks in LPS-challenged cells. Similar to IFN/T-L cells 
(Fig. 6a), SLE monocytes stimulated with LPS showed enrichment of IRF motifs, which 
likely is related to in vivo exposure to type I IFNs, and was not observed in control 
monocytes stimulated with LPS (Fig. 8e). Overall, the results show similarities in LPS-
induced chromatin accessibility in Class 1 genes between SLE monocytes and IFN-α-treated 
tolerized monocytes, suggesting that our model system mimics aspects of chromatin 
regulation in an IFN-mediated disease in vivo.
Discussion
Epigenomic reprogramming has been linked to tissue-specific macrophage 
phenotypes18–23,38,39, but how reprogramming affects inflammatory responses is not well 
understood15,40–42. In this study we found that TNF and IFN-α reprogram the human 
macrophage epigenome to alter inflammatory responses to TLR4 stimulation. TNF induces 
a balanced response that limits potentially toxic induction of inflammatory NF-κB target 
genes, while enabling expression of antiviral, metabolic, and Jak-STAT target genes. Type I 
IFNs potentiated TNF inflammatory function by preventing the silencing of inflammatory 
genes. Mechanistically, type I IFNs and TNF cooperate to induce signals and transcription 
factors that prime chromatin at inflammatory gene promoters to make them responsive to 
weak signals, and also resistant to suppression by IL-10. Overall, our findings identify a new 
function of type I IFNs, and reveal that signaling crosstalk between IFN-α and TNF is 
integrated at the level of chromatin to crossregulate transcriptional responses to LPS.
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There are important differences between TNF-induced reprogramming and previously 
described ‘endotoxin tolerance’. These include the abrogation of TNF-induced silencing of 
T genes by type I IFNs and the nature of the ‘NT’ response, which determines the 
macrophage functional phenotype. The ability of an endogenous cytokine like IFN-α to 
prevent silencing of T genes suggests that such ‘tolerization’ is a physiological process that 
is regulated by cytokines to fine tune the magnitude, duration, and qualitative nature of 
inflammatory responses, rather than a ‘last ditch effort’ to prevent endotoxin toxicity that 
can lead to profound immunosuppression and death. On the other hand, increased expression 
of type I IFNs, as occurs in several autoimmune diseases, will inactivate an important TNF-
induced homeostatic mechanism that places a ‘brake’ on inflammatory gene expression and 
can contribute to inflammatory pathogenesis.
Our results provide substantial new insights about the functions and mechanisms regulating 
expression of genes that are effectively or synergistically activated by LPS in TNF-
pretreated macrophages (the ‘ NT response’). One notable finding is discovery of Class 3, 
which is comprised of NT genes important for cytokine-Jak-STAT and IFN-antiviral 
responses. Induction of these genes is functionally important, as it allows cells exposed to 
TNF-driven inflammation to preserve antiviral host defense. Interestingly, Class 3 genes are 
tolerized (silenced) in the classical endotoxin tolerance model, as endotoxin induces 
additional and stronger tolerance mechanisms than does TNF3. Accordingly, compromised 
antiviral responses, superinfection, and reactivation of latent viruses are major complications 
in sepsis patients with endotoxin-tolerized cells. We have also identified new classes of ‘NT 
genes’, new functions, potential roles for transcription factors including SREBP2, AP-1 and 
E box proteins, and chromatin-based mechanisms that enable robust NT gene induction. A 
primed chromatin state, especially high H3K4me3, can greatly reduce requirements for 
activation of gene transcription43 and facilitate robust transcriptional responses to weak 
signals. The results overall are consistent with a ‘sequential rheostat’ model where 
environmental cues can independently regulate the intensity of upstream signaling and the 
accessibility of downstream chromatin. In this model, closed chromatin can block a strong 
signal, whereas open/primed chromatin can amplify a weak signal, in a gene-specific 
manner.
Type I IFNs have pleiotropic immune stimulatory and suppressive effects6. Little is known 
about mechanisms that determine context-dependent type I IFN functions. Classically, type I 
IFNs promote inflammation/immunity by inducing transcription of ISGs that harbor binding 
sites for ISGF3/STATs/IRFs and encode chemokines and antigen-presenting molecules. 
Previous reports, in line with our results, showed that NF-κB-driven inflammatory cytokine 
genes, such as those that comprise Class 1, are not induced and if anything are suppressed 
by type I IFNs6,8,9,44. In sharp contrast, in the context of co-treatment with TNF, IFNAR 
signaling was coupled to NF-κB target genes, as it prevented tolerization of a large fraction 
of Class 1 and 2 genes. Thus, in addition to induction of canonical ISGs, type I IFNs 
regulate chromatin at distinct inflammatory and possibly other gene sets. This regulatory 
role likely extends beyond the system used in this study, and may contribute to phenomena 
such as innate immune training22,42 and maintenance of basal immune responsiveness by 
commensal microbiota, which has been linked to IFNs and increased H3K4me3 at Tnf and 
Il6 promoters7,45.
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Genomic regulatory sequences show less conservation between human and mouse than do 
coding sequences. One advantage of using a human macrophage experimental system is that 
it enables direct comparisons with pathogenic macrophages obtained from clinical samples. 
It is encouraging that our results model aspects of gene expression or chromatin regulation 
patterns in monocytes/macrophages from patients with sepsis/recovery, RA and SLE37. SLE 
is characterized by IFN production and TLR activation in which TNF can be protective 
(consistent with tolerizing inflammatory genes). These similarities support the utility of our 
system to model and dissect mechanisms relevant for disease pathogenesis. It will be 
interesting to test in future work whether type I IFNs promote SLE pathogenesis in part by 
preventing tolerization of inflammatory ‘T’ genes, as has already been suggested36. Equally 
importantly, the mechanisms we have discovered and data sets we have developed provide 
molecular signatures linked to pathogenic cytokines and pathways that can motivate and 
help guide interpretation of studies using patient samples. Finally, our in vitro model can be 
exploited to develop and test the efficacy of therapeutic approaches that target epigenetic 
mechanisms that regulate cytokine production.
In summary, our results reveal how signaling crosstalk between type I IFNs, TNF and TLR4 
is integrated at the level of chromatin, and associate these chromatin changes with 
reprogramming of gene expression. They highlight the concept that chromatin is not just a 
target that propagates signaling cascades, but instead serves as an integration node that 
determines transcriptional output. These findings provide insights into regulation of 
inflammatory gene expression that can be used to develop approaches to modulate 
macrophage activation and cytokine production by targeting chromatin regulators.
METHODS
Cell culture, purification and stimulation
Primary human CD14+ monocytes were isolated from buffy coats purchased from the New 
York Blood Center using anti-CD14 magnetic beads (Miltenyi Biotec) as previously 
described, using a protocol approved by the Hospital for Special Surgery Institutional 
Review Board. Monocytes were cultured in RPMI 1640 medium (Invitrogen) supplemented 
with 10% heat-inactivated defined FBS (HyClone Fisher), penicillin/streptomycin 
(Invitrogen), L-glutamine (Invitrogen), and 20 ng/ml human macrophage colony-stimulating 
factor (M-CSF; Peprotech). Recombinant human TNF and IFN-α were from Peprotech and 
PBL science respectively (endotoxin concentrations were below limit of detection (<0.1 pg/ 
g)). LPS (tlrl-3pelps) and SB216763 (S3442) were from Invivogen and Sigma respectively.
Analysis of mRNA and protein
Total RNA was extracted with an RNeasy Mini Kit (Qiagen) and was reverse-transcribed 
with a First Strand cDNA Synthesis kit (Fermertas). Real-time PCR was performed in 
triplicate with Fast SYBR Green Master Mix and 7500 Fast Real-time PCR system (Applied 
Biosystems). Whole-cell extracts were prepared as described and were fractionated by 7.5–
10% SDS-PAGE, transferred to polyvinylide fluoride membranes (Millipore) and incubated 
with specific antibodies, then enhanced chemiluminescence was used for detection 
(Amersham). Antibody to phosphorylated IKKβ (2697), Erk (4377) and STAT1 (9171), and 
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antibody to IκBα (4812), p105/p50 (3035), cRel (4727), p100/p52 (3017), and RelB (4922) 
were from Cell Signaling. Anti-p38 (sc-535) was from Santa Cruz Biotechnology.
RNA-sequencing
After RNA extraction, libraries for sequencing were prepared using the Illumina TruSeq 
Stranded Total RNA Library Prep Kit following the manufacturer’s instructions. High 
throughput sequencing (50 bp, paired end) was performed at the Weill Cornell Medicine 
Epigenomic Core Facility. More than 100 million reads were obtained for each sample. 
After quality filtering according to the Illumina pipeline, paired-end reads were mapped to 
reference human genome (hg19 assembly) using STAR aligner version 2.4.0 with default 
parameters. Transcript abundance was quantified using Cufflinks 2.2.1, and Cuffdiff version 
2.2.1 was used to determine differentially expressed genes. The expression levels of genes in 
each sample were normalized by means of fragments per kilobase of exon per million 
fragments mapped (FPKM). Independently processed replicates from three different donors 
showed high similarity (the lowest r value across samples was 0.86 for all genes (Refseq) 
and 0.9316 for LPS-inducible genes (n = 1,574), Fig. 1 and Supplementary Fig. 1).
Chromatin Immunoprecipitation and ChIP-sequencing
Cells were crosslinked for 5 min at room temperature by the addition of one-tenth of the 
volume of 11% formaldehyde solution (11% formaldehyde, 50 mM HEPES pH 7.5, 100 
mM NaCl, 1 mM EDTA pH 8.0, 0.5 mM EGTA pH 8.0) to the growth media followed by 5 
min quenching with 100 mM glycine. Cells were pelleted at 4°C and washed with ice-cold 
PBS. The crosslinked cells were lysed with lysis buffer (50 mM HEPES-KOH pH 7.5, 140 
mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, and 0.25% Triton X-100) with 
protease inhibitors on ice for 10 min and washed with washing buffer (10 mM Tris-HCl, pH 
8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) for 10 min. The lysis samples were 
resuspended and sonicated in sonication buffer (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 
mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate, 0.5% Nlauroylsarcosine) using a 
Bioruptor (Diagenode) with 30 sec ON, 30 sec OFF on high power output for 18 cycles. 
After sonication, samples were centrifuged at 12,000 rpm for 10 minutes at 4°C and 1% of 
sonicated cell extracts was saved as input. The resulting whole-cell extract was incubated 
with Protein A Agarose for ChIP (EMD Millipore) for 1 hr at 4°C. Precleared extracts were 
then incubated with 50 µl (50% v/v) of Protein A Agarose beads for ChIP (EMD Millipore) 
with 5–10 µg of the appropriate antibody overnight at 4°C. ChIP grade antibodies against 
H3K 4me3 (ab8580), H3K27ac (ab4729), H3K36me3 (ab9050) and IRF1 (ab26109, ChIP-
qPCR) were from Abcam. Antibody against H2Bub (5546), p65 (8242, ChIP-qPCR) was 
from Cell Signaling Technology. ChIP antibodies against H3K56ac (39281) and H3K79me2 
(39143) were from Active Motif. Antibody against H4ac (06-866) was from EMD Millipore. 
Antibodies against Pol II (sc-899), IRF1 (sc-497, ChIPmentation) and p65 (sc-372) were 
from Santa Cruz Biotechnology. After overnight incubation, antibody-bound agarose beads 
were washed twice with sonication buffer, once with sonication buffer with 500 mM NaCl, 
once with LiCl wash buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 250 mM LiCl, 1% 
NP-40), and once with TE with 50 mM NaCl. ChIPmentation was perfomed as described46 
using magnetic beads (Thermo Scientific, 26162). The beads were washed twice with 10 
mM cold Tris-HCl, pH 8.0, to remove detergent, salts and EDTA. Subsequently, beads were 
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resuspended in 30 µl of the tagmentation reaction buffer (10 mM Tris, pH 8.0, 5 mM MgCl2) 
containing 1 µl Tagment DNA Enzyme from the Nextera DNA Sample Prep Kit (Illumina) 
and incubated at 37 °C for 10 min. Following tagmentation, the beads were washed twice 
with TE with 50 mM NaCl. After washing, DNA was eluted in freshly prepared elution 
buffer (1% SDS, 0.1M NaHCO3). Cross-links were reversed by overnight incubation at 
65°C. RNA and protein were digested using RNase A and Proteinase K, respectively and 
DNA was purified with ChIP DNA Clean & Concentrator™ (Zymo Research). For ChIP 
assays, immunoprecipitated DNA was analyzed by quantitative real-time PCR and 
normalized relative to input DNA amount. For ChIP-seq experiments, 10 ng of purified 
immunoprecipitated DNA per sample was ligated with adaptors, and 100–300 bp DNA 
fragments were purified to prepare DNA libraries using Illumina TruSeq ChIP Library Prep 
Kit following the manufacturer’s instructions. For ChIPmentation experiments, we amplified 
library fragments using 1× NEB next PCR master mix and 1.25 M of custom Nextera PCR 
primers as previously described46, using the following PCR conditions: 72 °C for 5 m in; 
98 °C for 30 s; and thermocycling at 98°C for 10 s, 63°C for 30 s and 7 2°C for 1 min. The 
libraries were purified using a Qiagen PCR cleanup kit yielding a final library concentration 
of ~30 nM in 20 µL. Libraries were amplified for a total of 8–10 cycles. ChIP libraries were 
sequenced (50 bp single end reads) using an Illumina HiSeq 2500 Sequencer at the Weill 
Cornell Medicine Epigenomic Core Facility per manufacturer's recommended protocol. For 
input DNA to be used as control for background noise, we fragmented 1 ng of chromatin for 
each sample, which underwent all steps of the ChIP-seq protocol except for 
immunoprecipitation and washing. Then, sequenced reads were aligned to reference human 
genome (GRCh37/hg19 assembly) using Bowtie2 version 2.2.6 with default parameters, and 
clonal reads were removed from further analysis. A minimum of 10 million uniquely 
mapped reads were obtained for each condition. Data in figures are from one representative 
out of two independent experiments (H2Bub, H3K4me3 and H3K36me3) with different 
blood donors or one experiment (H4ac, H3K27ac, H3K56ac, H3K79me2, H3K27me3 and 
H3K9me3).
ATAC-seq
ATAC-seq was performed as previously described41. To prepare nuclei, we spun 50,000 cells 
at 500g for 5 min, which was followed by a wash using 50 mL of cold 1× PBS and 
centrifugation at 500g for 5 min. Cells were lysed using cold lysis buffer (10 mM Tris-HCl, 
pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 0.1% IGEPAL CA-630). Immediately after lysis, 
nuclei were spun at 500g for 10 min using a refrigerated centrifuge. Immediately following 
the nuclei prep, the pellet was resuspended in the transposase reaction mix (25 µL 2× TD 
buffer, 2.5 µL transposase (Illumina) and 22.5 µL nuclease- free water). The transposition 
reaction was carried out for 30 min at 37 °C. Directly following transposition, the sample 
was purified using a Qiagen MinElute kit. Then, we amplified library fragments using 1× 
NEB next PCR master mix and 1.25 M of custom Nextera PCR primers as previously 
described, using the following PCR conditions: 72 °C for 5 min; 98 °C for 30 s; and 
thermocycling at 98°C for 10 s, 63°C for 30 s and 72°C for 1 min. The libraries were 
purified using a Qiagen PCR cleanup kit yielding a final library concentration of ~30 nM in 
20 µL. Libraries were amplified for a total of 10–13 cycles and were subjected to high-
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throughput sequencing using the Illumina HiSeq 2500 Sequencer (single end). ATAC-seq 
data was aligned to the genome using the same pipeline as ChIP-seq data.
Peak calling and annotation
We used the makeTagDirectory followed by findPeaks command from HOMER version 
4.7.2 (http://homer.salk.edu/homer/) to identify peaks of ChIP-seq and ATAC-seq. A false 
discovery rate (FDR) threshold of 0.001 was used for all data sets. The following HOMER 
command was used: cmd = findPeaks <sample tag directory> -style histone (for histone 
modifications and ATAC-seq) or factor (for transcription factors) -o <output file> -i <input 
tag directory for ChIP-seq>. Super-enhancers were identified using H3K27ac ChIP-seq data 
in HOMER using the findPeaks –style super, –L 0 and –i < input sample > options. The total 
number of mapped reads in each sample was normalized to ten million mapped reads. Peak-
associated genes were defined based on the closest genes to these genomic regions using 
RefSeq coordinates of genes. We used the annotatePeaks command from HOMER to 
calculate ChIP-seq and ATAC-seq tag densities from different experiments and to create 
heatmaps of tag densities. Sequencing data were visualized by preparing custom tracks for 
the UCSC Genome browser.
Classification of chromatin regions
Gene promoters were assigned to the genomic region within ±2 kb of a TSS (hg19). To 
determine potential enhancers, peaks of H3K27ac and ATAC-seq within 2 kb of a gene TSS 
were filtered out, then only peaks of ATAC-seq which overlapped with H3K27ac peaks were 
selected for the further analysis. For latent enhancers, we used peaks that have (1) up-
regulated tag density of H3K4me1 with ATAC-seq in T or TL conditions and (2) no 
H3K27ac in N or L conditions. All enhancer peaks between the different conditions in each 
comparison were merged into one peak set using mergePeaks –size given. Each enhancer 
was assigned to the nearest TSS. CpG database was retrieved from the UCSC Genome 
browser (hg19).
Clustering and correlation analysis
To generate the heatmap of K-mean clusters with RNA-seq, we used Cluster 3.0 (http://
bonsai.hgc.jp/~mdehoon/software/cluster/software.htm) K-means algorithm with the 
Euclidean distance metric. K was chosen at 12 because lower values failed to identify all 
meaningful clusters and higher values subdivided meaningful clusters. The clusters were 
grouped into gene classes based primarily upon pattern of gene expression in the 4 
experimental conditions (Fig. 1b) also taking into account the quantitative pattern of 
expression of each cluster (Supplementary Fig. 1a). For clusters that were on the border 
between two classes and difficult to assign solely based on pattern of gene expression, class 
assignment was supported by gene ontogeny analysis and similarity in induction kinetics 
(Supplementary Fig. 2a). For the correlation heatmap in Figure 8a, we calculated the 
pairwise Pearson’s correlation between samples (and replicates) using the ATAC-seq read 
density of gene promoters. To generate heat maps, we used GENE-E (http://
www.broadinstitute.org/cancer/software/GENE-E/) set to relative comparison. 
Representative genes in Fig. 1d and 4c were selected based on GSEA hallmark gene sets, 
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which summarize and represent specific well-defined biological states and display coherent 
expression.
Gene ontology analysis
For expression data in Fig. 1c, GO annotation was determined using the Gorilla (http://cbl-
gorilla.cs.technion.ac.il/) tool on each of the 6 classes in Fig. 1b (using a ranked list as 
input). One representative category based on p-value is depicted if more than one similar 
category was identified. For super enhancers, enriched pathways were compiled from the 
GREAT (http://bejerano.stanford.edu/great/public/html/) tool. In both cases, pathways were 
ranked using p-value or binomial p-value respectively.
Digital genomic footprinting
Our ATACseq datasets (number of samples: 28; mean of total aligned read counts: 
1.425×108) and signal to noise ratios sufficient to undergo digital genomic footprinting. For 
this purpose, the wellington_footprints (http://pythonhosted.org/pyDNase/index.html) 
function of the Wellington suite was used with standard parameters (p-value score, threshold 
10−10) on BED3-converted peaks. Then, the footprints associated with LPS-inducible genes 
(Fig. 1b) at the p value of 10−10 were selected for the further study. To visualize footprints as 
heatmap showing enrichment of known transcription factors (Fig. 2c), we used pyDNase 
command ‘dnase_to_javatreeview.py’ to generate a CSV file that can be used in 
JavaTreeView or GENE-E.
Motif enrichment analysis
We used findMotifs function of HOMER to analyze the promoters of genes for motifs that 
are enriched in target gene promoters relative to other promoters (−300bp < TSS < +50bp, 
Fig. 1e). For the motif analysis comparing different conditions in Fig. 3a and Supplementary 
Fig. 5e, we used the known motif results to find which motifs in the HOMER and JASPAR 
databases were enriched in our data sets according to HOMER2 (p ≤ 10−5). Motifs 
corresponding to 1) TFs not expressed in our experimental setup or 2) low % of targets 
sequences (<2%) were excluded from the analysis. De novo transcription factor motif 
analysis was performed with motif finder program findMotifsGenome from HOMER 
package, on given ATAC-seq footprints. Peak sequences were compared to random genomic 
fragments of the same size and normalized G+C content to identify motifs enriched in the 
targeted sequences.
Determining relationships between transcription factor motifs and chromatin regulation
To obtain the results shown in Fig. 6b, occurrences of motifs from the JASPAR database 
were identified by running HOMER on the hg19 reference sequence with a detection 
threshold of P < 10−5. Highly enriched motifs were manually chosen based on well-known 
functions of transcription factors for macrophage activation. For each of our experimental 
conditions we scored each motif’s association with chromatin accessibility and histone 
modifications. We then used the GraphPad Prism 6 to visualize the distribution of this motif 
across different experimental conditions.
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Analysis of patient monocytes and macrophages
Peripheral blood was obtained from SLE patients and healthy donors using a protocol 
approved by the Institutional Review Board at the Hospital for Special Surgery. As described 
above, human CD14+ monocytes/macrophages were purified using anti-CD14 magnetic 
beads and were cultured in RPMI-1640 medium with 10% (vol/vol) FBS (Hyclone). For RA 
synovial macrophages, the microarray data described in Donlin et al., J Immunol, 2014, 
193:2373 (GSE97779) were normalized by a quantile normalization method using the 
preprocessCore package in R. Normalized expression levels were averaged within the same 
condition (Fig. 3e, f). ATAC-seq with monocytes from healthy or patient donors (Fig. 8) was 
performed as described above with or without ex vivo LPS (10 ng/ml) stimulation. The 
datasets from sepsis patients (Fig. 3d) were retrieved from GSE46955.
Statistical analysis
Graphpad Prism 6 for Mac (GraphPad Software, Inc) was used for all statistical analysis. 
Detailed information about statistical analysis including tests and values used, and number 
of times experiments were repeated, is indicated in the figure legends. P values are provided 
in the text or the figure legends.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Pretreatment with TNF reprograms subsequent TLR4 response in human macrophages. (a) 
Experimental design: N, no treatment; L, no pretreatment, followed by LPS challenge; T, 
pretreatment with TNF; T-L, pretreatment with TNF and challenge with LPS; hCD14+, 
human CD14 positive monocyte-derived macrophages. (b) K-means clustering (K = 12) of 
1,574 LPS-induced genes (>3-fold) in the indicated conditions; heat map shows gene 
expression relative to maximum, set at 1. 12 clusters were assembled into 6 major Classes 
(see Methods). Bar graphs represent pooled data from three biological replicates (% of 
maximum value) for a given class. (c) Functionally enriched Gene Ontology (GO) categories 
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of the gene classes in Fig. 1b. (d) Heatmaps of representative genes from Classes 1, 3, and 4 
that correspond to distinct biological functions. (e) Motifs enriched in the promoters 
(−300bp < TSS < +50bp) of given Class genes using GC-corrected background set of all 
other promoters using HOMER. Data (c–e) are representative of three biological replicates 
with similar results.
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Figure 2. 
Distinct epigenetic landscape at different TLR4-induced gene classes. (a) Heatmaps of 
H4ac, H3K4me3, H2Bub ChIP-seq and ATAC-seq normalized tag densities at the promoters 
(−2kb < TSS < +2kb) of a given gene class based on Fig. 1b. The order of genes in each 
column is the same for all heatmaps and Fig. 1b. (see Supplementary Fig. 3a for 
quantitation). (b) Representative UCSC Genome Browser tracks displaying normalized tag 
density profiles for H4ac, H3K4me3, H2Bub ChIP-seq, ATAC-seq and RNA-seq signals at 
IL6 (Class 1), CCL5 (Class 3), and CH25H (Class 4) genes in the indicated conditions. 
Boxes enclose genomic regions showing differential regulation. Data (a and b) show results 
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from one representative donor; results from biological replicates (ChIP-seq) and pooled data 
from 3–5 replicates (ATAC-seq) are shown in Supplementary Fig. 4a. (c) Heatmaps showing 
per nucleotide ATAC-seq cleavage sites for NFκB-p65 and PU.1 motifs in LPS-stimulated 
human primary macrophages ranked by tag density. The number of ATAC-seq footprints for 
each TF is shown on y-axis. 200 bp windows are shown centered at the midpoints of the 
ATAC-seq footprint. Footprinting was performed with two independent ATAC-seq 
replicates.
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Figure 3. 
(a–c) Distinct transcription factor binding at different gene classes. (a) Heatmap of 
significantly enriched motifs (p < 10−5) within ATAC-seq footprints (p < 10−10) in gene 
class promoter regions (−2kb < TSS < +2kb) in indicated conditions. Motifs are grouped 
according to transcription factor families. (b) Immunoblot of nuclear lysates from 
macrophages stimulated overnight with TNF. (c) Bar graphs show cumulative values for 
representative TFs that match motifs in (a) from three replicates. (d–e) Expression of 
inflammatory gene classes in sepsis monocytes and RA synovial macrophages. (d) 
Expression of genes belonging to each gene class in healthy donor monocytes (CTL, n = 2), 
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or monocytes from patients during sepsis (Sepsis, n = 7) and after recovery from sepsis 
(Recovery, n = 7) stimulated ex vivo with or without LPS. Each dot represents the average 
(log2) of a gene class in an individual donor. Data are presented as mean ± SEM. The gene 
expression data are from GSE46955. ****p < 0.0001, **p<0.01, analysis of variance and 
Dunnett’s multiple comparison post hoc test. (e) Cumulative distribution plot of normalized 
gene expression (log2) of LPS-inducible, Class 3 and Class 4 genes in RA synovial 
macrophages (RA, n=8) and control macrophages (CTL, n=8). p-value: CTL vs. RA, 
Kolmogorov-Smirnov test. (f) Expression of representative Class 4 genes in control or RA 
macrophages. Data are presented as mean ± SEM. **** p < 0.0001, *** p < 0.001, ** p < 
0.01, * p < 0.05, unpaired Student’s t-test.
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Figure 4. 
Type I IFNs block TNF-mediated tolerization of inflammatory genes without affecting LPS 
signaling. (a) Experimental design: IFN, treatment with IFN-α (25 ng/ml); IFN-L, treatment 
with IFN-α, followed by LPS challenge (10 ng/ml); IFN/T, treatment with IFN-α and TNF 
(10 ng/ml); IFN/T-L, treatment with IFN-α and TNF, followed by LPS. (b) Bar graphs 
represent cumulative values for a given gene class in RNA-seq analysis (left) from three 
replicates (% of maximum value). Error bars indicate SEM. The dot plots (right) show 
percent of genes in each class that were up-regulated, down-regulated or not changed by 
IFN-α (>1.5-fold, T-L vs. IFN/T-L). Each dot represents 1% of genes; red = upregulated, 
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blue = downregulated, grey = not changed. ****p < 0.0001, *p<0.05, analysis of variance 
and Dunnett’s multiple comparison post hoc test. (c) Heatmap showing inflammatory Class 
1 genes whose tolerization is reversed by IFN-α treatment. (d) Immunoblot analysis of 
IκBα, p105/p50, cRel, p100/p52, RelB and phosphorylated IKKβ, ERK and STAT1 in 
primary macrophages cultured for 24 h with TNF (10 ng/ml) with or without IFN-α (25 ng/
ml), and challenged for the indicated times with LPS (10 ng/ml). Data are representative of 
four experiments. (e) RT-qPCR analysis of TNF and IL6 primary transcripts normalized 
relative to HPRT. Data are representative of five independent donors and error bars indicate 
SEM. (f) ChIP assays for recruitment of Pol II to IL6 promoter in the indicated conditions. 
Data are representative of 4 different donors.
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Figure 5. 
Integration of signaling crosstalk between IFN and TNF at the chromatin level. (a) 
Formaldehyde-assisted isolation of regulatory elements (FAIRE) assay at IL6 gene under 
indicated conditions. Data are representative of 4 experiments; error bars show SEM. (b) 
Heatmaps of ATAC-seq and H3K4me3, H2Bub ChIP-seq normalized tag densities at the 
promoters (−2kb < TSS < +2kb) of Class 1 genes ordered as in Fig. 1b (upper). Box graphs 
represent quantitation of the normalized tag densities (log2) for the indicated conditions. p 
value, Kolmogorov-Smirnov test. (c) Representative UCSC Genome Browser tracks 
displaying normalized profiles for ATAC-seq, H3K4me3 and H2Bub ChIP-seq signals at 
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TNF gene under indicated conditions. ATAC-seq data represents pooled data from three to 
five biological replicates. (d) Heatmap of breadth of H3K4me3 ChIP-seq peaks at Class 1 
gene promoters under indicated conditions (upper). Box graphs represent quantification of 
the H3K4me3 breadth (log2) for Class 1 genes (lower). p-value, Kolmogorov-Smirnov test. 
(e) Representative UCSC Genome Browser tracks displaying normalized profiles for ATAC-
seq signals at IL1B, DUSP2 and NFKBIA (Class 1) genes under indicated conditions. Boxes 
enclose ATAC-seq peaks that extended into gene bodies in IFN/T-L condition.
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Figure 6. 
IFN and TNF prime chromatin by cooperatively recruiting transcription factors to Class 1 
promoters. (a) De novo motif enrichment analysis of promoter regions (−2kb < TSS < +2kb) 
of Class 1 genes using ATAC-seq footprints of IFN/T-L condition. Random background 
regions were selected as a control. (b) Graphs represent association of occupied transcription 
factor binding sites (footprints) with chromatin accessibility and histone modifications. Data 
are presented as mean ± SEM. Relative chromatin accessibility or histone modification (x-
axis, normalized ATAC-seq, H2Bub or H3K4me3 tag counts) is measured as the mean 
intensity of ATAC-seq, H2Bub or H3K4me3 peaks containing the indicated motif (y-axis) 
across all experimental conditions. (c) Bar graphs represent cumulative values for IRF1, 4 
and 7 in RNA-seq analysis from three replicates.
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Figure 7. 
(a–c) Colocalization of IRF1 and NF-kB p65 in IFN-α and TNF-treated macrophages. (a) 
Circle represents 100% of Class 1 gene promoter IRF1 Chip-seq peaks in unstimulated (left, 
n = 147) or IFNα/T conditions (right, n = 386). The peak fraction that overlaps with p65 
ChIP-seq peaks is shaded in black. P value was calculated relative to random genes. (b) 
Representative UCSC Genome Browser tracks displaying normalized profiles for p65 and 
IRF1 ChIP-seq signals at IL1B and CCL3 genes in indicated conditions. Boxes enclose co-
localization of p65 and IRF1 binding peaks in the same genomic regions. (c) ChIP-qPCR 
analysis of recruitment of p65 and IRF1 to CCL3 and CCL20 promoters. Data are 
representative of three independent experiments. (d–e) Altered transcriptional requirements 
in IFN-α + TNF-treated macrophages. Naïve, TNF-, or IFN-α + TNF-treated macrophages 
were stimulated with LPS (10 ng/ml) with or without CHX (d, 20 µg/mL) or IL-10 (e, 10 
ng/ml) and RT–qPCR was performed. Data are representative of three independent donors, 
and error bars indicate SEM.
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Figure 8. 
Chromatin accessibility in SLE monocytes. (a) Correlation matrix heatmap based on 
unsupervised Pearson correlation coefficients comparing normalized ATAC-seq tag densities 
at promoters (−2kb < TSS < +2kb) of Class 1 genes across all indicated conditions and 
replicates. (SLE-N: untreated SLE monocytes, SLE-L: LPS (10 ng/ml)-treated SLE 
monocytes). (b) Representative UCSC Genome Browser tracks displaying normalized 
profiles for ATAC-seq signals at TNF, CXCL2 and CCL20 genes in indicated conditions. 
(CTL: control monocytes, SLE: SLE monocytes). Boxes enclose a broad region of 
chromatin accessibility that extends into the gene bodies in SLE monocytes. (c) Bar graph 
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represents cumulative values for IFNB1 in RNA-seq analysis under indicated conditions 
from three replicates. (d) UCSC Genome Browser tracks displaying normalized profiles for 
ATAC-seq signals at IFNB1 under indicated conditions. (CTL: control monocytes, SLE: 
SLE monocytes). Boxes enclose a broad region of chromatin accessibility that extends into 
the gene bodies in IFN/T-L and SLE-L conditions. (e) De novo motif enrichment analysis of 
Class 1 gene promoters using ATAC-seq footprints of LPS-stimulated control monocytes 
(CTL-L) and SLE monocytes (SLE-L).
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